Variables | Crude analysis | Adjusted analysis | ||
---|---|---|---|---|
PRc (95% CI) | p | PRa (95% CI) | p | |
Sex (n = 185) | 0.943* | NS | ||
Male | 0.98 (0.70-1.38) | |||
Female | 1 | |||
Age in years (n = 185) | 0.023 | 0.001 | ||
20-59 (adults) | 1.33 (1.04-1.71) | 1.90 (1.31-2.75) | ||
≥ 60 (elderly) | 1 | 1 | ||
Income in minimum wages (n = 154) | 0.007 | 0.008 | ||
0-2 | 1.87 (1.18-2.96) | 2.32 (1.24-4.36) | ||
> 2 | 1 | 1 | ||
Education in completed years (n = 176) | 0.000 | 0.676** | ||
0-4 | 1.64 (1.28-2.10) | 1.08 (0.74-1.58) | ||
> 4 | 1 | 1 | ||
Self-reported skin color (n = 178) | 0.669* | NS | ||
White | 1 | |||
Black + Brown | 1.1 (0.70-1.73) | |||
Presence of comorbidities (n = 181) | 0.019 | 0.464** | ||
No | 1 | 1 | ||
Yes | 1.37 (1.05-1.80) | 1.08 (0.74-1.58) | ||
Consultation with another rheumatologist (n = 181) | 0.900* | NS | ||
No | 1 | |||
Yes | 0.98 (0.73-1.31) | |||
Number of visits in the last 12 months (n = 176) | 0.121 | 0.619** | ||
0-2 | 1.03 (0.99-1.08) | 0.91 (0.65-1.28) | ||
≥ 3 | 1 | 1 | ||
Type of medical care (n = 163) | 0.637* | NS | ||
SUS | 1.06 (0.81-1.38) | |||
Private + Public-Private Partnership | 1 | |||
Diagnostic delay in months (n = 178) | 0.982* | NS | ||
0-3 | 1 | |||
≥ 4 | 1.01 (0.73-1.36) | |||
Disease time in months (n = 185) | 0.667* | NS | ||
0-24 | 1 | |||
≥ 25 | 0.91 (0.62-1.35) | |||
Current use of DMARDs (n = 168) | 0.729* | NS | ||
No | 0.94 (0.69-1.28) | |||
Yes | 1 | |||
Current use of biologicals (n = 172) | 0.184 | 0.481** | ||
No | 1.24 (0.90-1.71) | 1.17 (0.79-1.73) | ||
Yes | 1 | 1 | ||
HAQ (n = 110) | 0.017 | 0.017 | ||
0-1 | 1 | 1 | ||
1.1-3 | 1.66 (1.09-2.54) | 1.73 (1.10-2.72) | ||
Rheumatoid factor (n = 160) | 0.873** | NS | ||
0-60 (normal or low titer) | 1 | |||
≥ 61 (high titers) | 1.02 (0.77-1.35) | |||
Radiography of hands with joint erosion (n = 151) | 0.385** | NS | ||
No | 1 | |||
Yes | 1.14 (0.84-1.55) |